Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
María Carla Saleh is Full Professor at Institut Pasteur, where she directs the Viruses and RNAi unit within the department of Virology. She studies the antiviral response in insects and develops new vector control strategies to eliminate mosquito-borne diseases. During her postdoctoral training at the University of California, San Francisco, USA, she discovered that RNA interference was the antiviral immune system of insects.
Félix Augusto Rey directs the Structural Virology unit of Institut Pasteur, France, where he studies the entry mechanisms of lipid-enveloped viruses into cells by using structural approaches. Previously, he has been junior group leader at the CNRS and was chair of Institut Pasteur's Virology department between 2004 and 2012. During his post-doctoral training at Harvard University, USA, he determined the first structure of a flavivirus envelope protein.
Introduction xiMaría-Carla SALEH and Félix AUGUSTO REY
Chapter 1 DNA Viruses 1Lindsey M COSTANTINI and Blossom DAMANIA
1.1 Introduction to DNA viruses 1
1.1.1 What are the most abundant DNA viruses? 2
1.1.2 Human DNA viruses 4
1.2 Taxonomy and structure 6
1.2.1 Small DNA tumor virus, e.g human papillomavirus 7
1.2.2 Large DNA tumor virus, e.g Kaposi's sarcoma-associated herpesvirus 7
1.3 Genomes 8
1.3.1 HPV, a small DNA tumor virus genome 9
1.3.2 KSHV, a large DNA tumor virus genome 10
1.4 Gene expression and regulation 10
1.4.1 Small DNA tumor virus gene expression, the HPV example 12
1.4.2 Large DNA tumor virus gene expression, the KSHV example 13
1.4.3 DNA virus inhibition of cellular gene expression 14
1.5 Infectious cycle 15
1.5.1 Small DNA tumor virus life cycle, the HPV example 16
1.5.2 Large DNA tumor virus life cycle, the KSHV example 18
1.6 Viral-induced cellular survival 20
1.6.1 Small DNA tumor virus enhancement of cell survival, e.g HPV 21
1.6.2 Large DNA tumor virus enhancement of cell survival, e.g KSHV 21
1.7 Disease prevalence and prevention 22
1.7.1 HPV, a small tumor DNA virus and disease associations 22
1.7.2 KSHV, a large DNA tumor virus and disease associations 24
1.8 Conclusion 25
1.9 References 26
Chapter 2 Double-stranded RNA Viruses 33Michelle M. ARNOLD, Albie VAN DIJK and Susana LÓPE
2.1 Introduction 33
2.2 Rotaviruses 37
2.2.1 Virion structure 37
2.2.2 Genome 38
2.2.3 Virus entry 39
2.2.4 Transcription, replication and genome segment sorting 40
2.2.5 Host cell interactions: protein synthesis 41
2.2.6 Innate immune evasion 42
2.3 Reoviruses 43
2.3.1 The use of reovirus as an anti-cancer agent 43
2.3.2 Virion structure 43
2.3.3 Genome 44
2.3.4 Virus entry 44
2.3.5 Transcription and protein synthesis 45
2.3.6 RNA packaging and virion assembly 46
2.3.7 Innate immune evasion 48
2.4 Orbiviruses 49
2.4.1 Virion structure 51
2.4.2 Genome 51
2.4.3 Replication cycle 51
2.4.4 Virus entry 52
2.4.5 Transcription, (+)ssRNA selection and packaging, replication 52
2.4.6 Innate immune evasion 54
2.5 Concluding remarks and future challenges to understand dsRNA virus biology 55
2.6 References 56
Chapter 3 Negative-strand RNA Viruses 69Rachel FEARNS
3.1 Introduction 69
3.2 Replication cycles of negative-strand RNA viruses 70
3.2.1 The order Mononegavirales 70
3.2.2 The order Bunyavirales 73
3.2.3 The order Articulavirales 77
3.2.4 The genus Deltavirus 78
3.2.5 Summary of viral replication cycles 80
3.3 The transcription and replication machinery of the negative-strand RNA viruses 80
3.3.1 Overview of the different negative-strand RNA virus polymerases 80
3.3.2 Orthomyxovirus polymerases and their transcription and replication mechanisms 81
3.3.3 The bunyavirus polymerase 85
3.3.4 The mononegavirus polymerases and their transcription and replication mechanisms 86
3.3.5 Concluding remarks 90
3.4 References 91
Chapter 4 Viral Epitranscriptomics 105Rachel NETZBAND and Cara T PAGER
4.1 Introduction 105
4.1.1 What are epitranscriptomic marks? 105
4.1.2 How are epitranscriptomic marks installed? 106
4.2 The tools of RNA modification discovery 106
4.2.1 Chromatography and mass spectrometry 107
4.2.2 Sequencing methods for PTM detection 109
4.3 RNA modifications deposited by viral enzymes 113
4.3.1 Capping of 5' end of viral RNA by viral methyltransferases 113
4.3.2 2'O-methylation of viral RNA 114
4.4 Editing of viral RNA by cellular enzymes 120
4.4.1 Editing of uridine-to-pseudouridine (¿) 121
4.4.2 Editing of adenosine-to-inosine 123
4.5 Deposition of RNA modifications on viral RNA by cellular enzymes 129
4.5.1 Role of N6-methyladenosine (m6A) on viral gene expression 129
4.5.2 Role of 5-methylcytosine (m5C) in viral gene expression 136
4.5.3 The viral epitranscriptome 139
4.6 Conclusion 140
4.7 References 141
Chapter 5 Defective Viral Particles 159Carolina B LÓPEZ
5.1 Introduction 159
5.2 Discovery of defective viral genomes and early research 160
5.3 Classes of defective viral genomes 166
5.3.1 Mutations and frame shifts 168
5.3.2 Deletion DVGs 168
5.3.3 Copy-back and snap-back DVGs 169
5.3.4 Others 169
5.4 Impacts on the virus-host interaction 170
5.4.1 Interference with virus replication 170
5.4.2 Stimulation of the immune response 171
5.4.3 Antivirals and vaccines 173
5.4.4 Establishment of virus persistence 174
5.4.5 Impact on virus spread 175
5.5 Host factors affecting DVG accumulation and activity 175
5.6 Conclusion 176
5.7 References 176
Chapter 6 Enteric Viruses and the Intestinal Microbiota 197Matthew PHILLIPS, Bria F DUNLAP, Megan T BALDRIDGE and Stephanie M KARST
6.1 Introduction 197
6.2 Enteric picornaviruses 198
6.2.1 Intestinal microbiota enhance poliovirus stability 200
6.2.2 Bacterial glycans facilitate virion attachment to target cells 200
6.2.3 Intestinal microbiota promote poliovirus recombination 200
6.3 Mouse mammary tumor virus 201
6.3.1 MMTV binds LPS, which in turn promotes a tolerogenic immune environment conducive to viral persistence 202
6.3.2 MMTV incorporates host LPS-binding proteins into its envelope 202
6.4 Reoviruses 204
6.4.1 Intestinal microbiota enhance reovirus stability 204
6.4.2 Immunostimulatory properties of bacterial flagellin inhibit rotavirus infection 206
6.4.3 Segmented filamentous bacteria have direct and indirect antiviral activity against rotavirus 207
6.4.4 How to reconcile the seemingly contradictory observations of bacterial enhancement and bacterial suppression of rotavirus infection 207
6.5 Noroviruses 208
6.5.1 Intestinal microbiota can promote norovirus infection 209
6.5.2 Intestinal microbiota can trigger antiviral immune responses during norovirus infection 211
6.6 Astroviruses 213
6.6.1 Host interferon responses reduce astrovirus replication and infection 214
6.6.2 Dysbiosis can occur after AstV infection 214
6.6.3 In vivo and in vitro culture systems for AstV pathogenesis studies 215
6.7 Overall conclusion 216
6.8 References 217
Chapter 7 Plant-Virus-Vector Interactions 227Swapna Priya RAJARAPU, Diane E ULLMAN, Marilyne UZEST, Dorith ROTENBERG, Norma A ORDAZ and Anna E WHITFIELD
7.1 Introduction 227
7.2 Non-circulative virus transmission 228
7.2.1 Vectors of non-circulative viruses 230
7.2.2 Virus-vector interactions are highly specific 231
7.2.3 Capsid strategy 232
7.2.4 Helper strategy 232
7.3 Circulative virus transmission 234
7.3.1 Vectors of circulative viruses 234
7.4 Receptors in vectors of non-circulative viruses 235
7.4.1 Receptors in aphid stylets 236
7.4.2 Receptors in vector foreguts 237
7.5 Receptors in vectors of circulative viruses 237
7.5.1 Circulative virus binding and transcytosis 237
7.5.2 Circulative virus receptors 238
7.6 Circulative, propagative virus binding and entry 239
7.6.1 Circulative, propagative viruses binding and entry 239
7.6.2 Receptors in vectors of circulative, propagative viruses 241
7.6.3 Vertical transmission of propagative, circulative viruses 242
7.7 Virus transmission morphs for non-circulative viruses 243
7.8 "Omics" tools for studying virus-arthropod interactions 243
7.9 Vector innate immunity in response to viruses 247
7.10 Host and vector manipulation by plant viruses 250
7.10.1 Indirect (plant-mediated) manipulation of insect vectors by plant viruses 250
7.10.2 Direct manipulation of insect vectors by plant viruses 260
7.10.3 Mode of transmission and virus manipulation of plant hosts leading to enhanced vector transmission 262
7.11 Summary points 263
7.12 Acknowledgments 264
7.13 References 265
Chapter 8 Evolution and Origin of Human Viruses 289Rachele CAGLIANI, Alessandra MOZZI, Chiara PONTREMOLI, Manuela SIRONI
8.1 Introduction 289
8.2 Origin and ancient evolutionary history of human viruses 290
8.2.1 Origin and ancient evolutionary history of human-infecting RNA viruses 290
8.2.2 Origin and ancient evolutionary history of human-infecting reverse-transcribing viruses 295
8.2.3 Origin and ancient evolutionary history of human-infecting DNA viruses 298
8.3 Sources of viral genetic diversity 303
8.4 Viral evolution and host range 307
8.5 Recent evolution of human RNA viruses - selected examples 313
8.6 Conclusion 319
8.7 References 320
List of Authors 341
Index 345
María-Carla SALEH1 and Félix AUGUSTO REY2
1 Viruses and RNAi Unit, Institut Pasteur and CNRS UMR 3569, Paris, France
2 Structural Virology Unit, Institut Pasteur and CNRS UMR 3569, Paris, France
Viruses are ubiquitous and have been a major driver in the evolution of life on Earth. Without viruses, life would certainly not be as we know it. Viruses are intimately linked to cells: invading a cell is mandatory for their reproduction and perpetuation in nature. The origin of viruses goes back to the origin of life, which emerged from primitive self-replicating nucleic acid molecules. The viruses that are mostly studied are those that cause disease in humans, animals or plants; however, disease-causing viruses are only an epiphenomenon in the global picture of the origin and evolution of life. Most viruses have evolved with their host and do not cause disease. Virus pathogenicity is most often the result of a change of context, such as the infection of new hosts in which they have not evolved and adapted. A good example is constituted by zoonotic viruses, such as the Ebola virus or the current coronavirus that is responsible for the COVID-19 pandemic, which are bat viruses and do not cause disease in their natural host.
Viruses have genome coding for all of the information required for their perpetuation in nature. Some viruses have very small genomes, while others have very large genomes. Baltimore introduced a classification of viruses into different groups, according to the way the viral genome produces messenger RNA once inside the cell, so that they can be translated into viral proteins (Baltimore 1971). There are seven virus groups according to this criterion, the simplest one being those in which the genome is a positive-sense, single-stranded RNA (+ssRNA) molecule (group IV in Baltimore's classification), which can be directly translated by the ribosomes in a cell. There is no transcription step required for group IV viruses, and the naked
genome is infectious, contrary to the RNA viruses in the other groups. One of the virally encoded enzymes is polymerase, which is capable of replicating the +ssRNA genome to make more progeny within the cell, as cells normally lack RNA-directed RNA polymerase activity. The replication of viruses in group IV takes place in the cytoplasm of the cell. Viruses in the other groups require the transcription of their genome in order to produce messenger RNA. Most of them encode viral polymerase, which needs to first transcribe the genome into messenger RNA to synthesize the viral proteins. In this case, the viral RNA is only infectious in association with the viral polymerase, and it is this complex that is delivered into the cytoplasm of the cell for a productive infection. After the initial transcription round, replication ensues - i.e. the synthesis of more genomic RNA - often using the same virally encoded polymerase, which has dual transcriptase and replicase activities - to be incorporated into new viral particles. For viruses in Baltimore groups VI and VII, the viral polymerase is a "reverse transcriptase" (RT). In group VI, the genome is a +ssRNA molecule that is not used as a messenger, but is transformed by RT into double-stranded DNA (dsDNA) that gains the cell nucleus and is integrated into the host cell genome to be transcribed by cellular polymerases. In the viruses in group VII, the genome is a DNA molecule that is maintained as an episome in the nucleus of the infected cell (i.e. it is not integrated into the host genome), in the form of a covalently closed circular DNA (cccDNA), like in the hepatitis B virus (HBV). This DNA genome is transcribed by cellular polymerase, and the RNA of full-length transcripts, called pregenomic RNA (prgRNA), is incorporated, along with RT, into newly formed viral particles. Once inside the particle, RT transforms the prgRNA into an incomplete double-stranded linear DNA genome that will be used to infect other cells.
This book provides several snapshots into the universe of viruses. They provide more detail on the replication of viruses in the most complex groups in the Baltimore classification. In Chapter 1, Lindsey M. Costantini and Blossom Damania discuss the replication of DNA viruses, which belong to Baltimore groups I (dsDNA viruses) and II (ssDNA viruses), as well as HBV (group VII). Most of these viruses replicate in the nucleus of the cell, but there are exceptions, such as the poxviruses. This chapter also highlights the specific features of some of the DNA viruses causing serious diseases in humans, notably the so-called oncogenic viruses, showing that some become integrated into the host genome, but others remain as episomes. In Chapter 2, Michelle M. Arnold, Albie van Dijk and Susana López analyze the life cycle of the viruses in group III, which have a double-stranded RNA genome that is always contained in an icosahedral proteinaceous capsid. This protein shell protects these viruses from the detection of their genomes by the cell. Indeed, dsRNA is not normally present in a cell, and therefore constitutes a pathogen-associated molecular pattern (PAMP) that is recognized by pattern recognition receptors (PRRs), which trigger the innate immune system of the host. For this reason, all RNA viruses have developed the means to isolate their replication compartments, in which transient dsRNA molecules form without being exposed to PAMPs.
In Chapter 3, Rachel Fearns describes the replication of viruses in group V, which have a negative-sense ssRNA genome in complex with a protein (termed "N" for nucleoprotein) that polymerizes all along the genome, and is associated with a large viral polymerase that is first used for transcription and then for replication. Some of these viruses have a segmented genome. While most of them replicate in the cytoplasm, some gain the nucleus for replication, for example the influenza virus. This chapter also describes the replication of one of the smallest viruses that infects humans, the hepatitis delta virus (HDV). Although it has a negative-sense ssRNA genome, it is so small that it does not code for a polymerase enzyme, nor for a capsid protein: it instead uses the capsid and envelope protein of a co-infecting HBV to propagate to other cells. For its replication, the HDV genome enters the nucleus and co-opts the cellular RNA polymerase II, which normally only transcribes DNA, for its own transcription and replication. This is a remarkable ability of this virus, to make cellular enzymes work in a different way for its own benefit.
Viruses can also hijack the metabolic pathways of a cell in order to make progeny and convert the cell into a virus-producing factory. During evolution, however, there is a constant arms race in which cells fight back - or more precisely, the whole organism fights back, sacrificing infected cells so that the infected organism survives as a whole. The PRRs detect foreign motifs (PAMPs) in the cell by using different mechanisms, in order to trigger a strong innate immune response that leads to the death and elimination of the infected cell. Viruses, in turn, have developed ways to counter this detection. In Chapter 4, Rachel Netzband and Cara T. Pager describe the extensive epigenetic modifications of viral nucleic acids that make them appear like cellular RNA and avoid or limit their detection by PRRs. On the contrary, it is in the virus' benefit to avoid killing its host. In Chapter 5, Carolina B. López describes the defective interfering particles generated by deletions, or other defects, in the replicated viral genome, which trigger the innate immunity of the cell. This delicate balance allows the virus to become persistent, with replication only at a basal level, protecting its host but ensuring its viability. This is another illustration of the constant interplay between viruses and cells during evolution, both mutually adapting in a race that is reminiscent of the Red Queen in Lewis Carrol's fiction Through the Looking-Glass (1871), constantly running to stay in the same place.
Evolution has been such that viruses have developed highly specific and sophisticated ways of interacting with their host. In Chapter 6, Matthew Phillips, Bria F. Dunlap, Megan T. Baldridge and Stephanie M. Karst illustrate the way enteric viruses co-opt the intestinal flora in order to augment their infectiveness. They bind to bacterial polysaccharides or other structures with high affinity and specificity, in order to use them as vehicles to efficiently reach their target cells in the intestinal epithelium. Similarly, viruses that are transmitted by arthropod vectors - notably insects or ticks - have evolved very efficient and specific ways of interacting with their vector in order to be transported and maximize their chances of finding new, uninfected hosts. Such an example is described in Chapter 7 by Swapna Priya Rajarapu, Diane E. Ullman, Marilyne Uzest, Dorith Rotenberg, Norma A. Ordaz and Anna E. Whitfield, who analyzed the interactions of plant viruses with their insect vectors. Some viruses have developed highly efficient ways to bind to an insect's mouth while it feeds on an infected plant, so that they can be transported to other susceptible plants. Some plant viruses replicate in their vector, and change insect behavior so that it is more attracted to uninfected plant hosts, thereby spreading the infection more easily. They further discuss the role of bacterial endosymbionts in the vertical transmission of viruses in the vector species, as a way of maintaining the virus even when...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.